Seoul, South Korea

Gun Woo Ha

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bionote Inc.. Active years: 2012.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gun Woo Ha: Innovator in Canine Influenza Research

Introduction

Gun Woo Ha is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of veterinary medicine, particularly in the area of canine influenza. His work focuses on developing vaccines and diagnostic tools to combat this viral infection in dogs.

Latest Patents

Gun Woo Ha holds a patent for a vaccine composition targeting the canine influenza virus. The patent, titled "Canine influenza virus and vaccine therefore," discloses novel influenza viruses A/Canine/Korea/01/07 (H3N2), A/Canine/Korea/02/07 (H3N2), and A/Canine/Korea/03/07 (H3N2). The patent also includes a method for preventing or treating diseases resulting from influenza virus infection by administering the vaccine composition, as well as an assay kit for detecting the viruses.

Career Highlights

Gun Woo Ha is associated with Bionote Inc., a company dedicated to advancing veterinary diagnostics and therapeutics. His innovative work has positioned him as a key figure in the development of solutions for canine health issues.

Collaborations

He collaborates with notable colleagues, including Young Shik Cho and Bo Kyu Kang, who contribute to his research efforts and innovations in the field.

Conclusion

Gun Woo Ha's contributions to canine influenza research exemplify the importance of innovation in veterinary medicine. His work not only enhances the health of dogs but also showcases the potential for advancements in animal healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…